In 2004, Tranzyme Pharma adopted an equity compensation plan, the Tranzyme Pharma 2004 Stock Option Plan (the 2004 Plan), which authorized shares of Tranzyme Pharma???s common exchangeable stock for granting stock options to employees, directors and consultants and other individuals set forth in the 2004 Plan.